Condition: Transgender · Gut Microbiome · Immune System · Sponsor: Charite University, Berlin, Germany
The XCVD study investigates the influence of sex hormones on the composition of the gut microbiome and the possible emergence of cardiovascular risk factors. It will follow 200 healthy transgender individuals for five years during their hormone replacement therapy (HRT) and analyze them for the possible emergence of cardiovascular risk factors in relation to changes in the gut microbiome, metabolome, and immunome. We would also like to phenotype cardiovascular disease.
This description comes directly from the study's public registry record.
Sofia Forslund, Prof. Dr. · +49 30 450540649 · sofia.forslund@mdc-berlin.de
Lajos Marko, Dr. · lajos.marko@charite.de
Always discuss trial participation with your own doctor first.
| Experimental and Clinical Research Center, Clinical Research Unit | Berlin, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05334888